Adora Ndu serves as Executive at ACADIA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Adora Ndu has executed 3 insider transactions totaling $1.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 29, 2024 involved exercising options for 6,652 shares valued at $0.
Adora Ndu currently holds 11,033 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adora Ndu has been a net buyer of ACAD stock. They have purchased $1.6K and sold $0 worth of shares.
Adora Ndu's most recent insider trade was on May 29, 2024, when they sold 6,652 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.89 |
| Discretionary |
| Oct 12, 2023 | ACAD | $0 | Option Exercise | 4,381 | $N/A | Discretionary |